ArriVent BioPharma, Inc. (AVBP)
Nasdaq: AVBP · Pharmaceutical Preparations · Newtown Square, PA · filing with the SEC since 2021
Who runs ArriVent BioPharma, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Yao Zhengbin
President and CEO. First filing Jan 2024, latest Feb 4, 2026, 0 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
16 people on the record since 2024
Officerssales are open-market, Nov 2, 2025 to Nov 2, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Lachapelle Robin | Chief Operating Officer | Jan 2024 | Nov 2, 2026 | none |
| Yao Zhengbin | President and CEO | Jan 2024 | Feb 4, 2026 | none |
| Lutzker Stuart | President of R&D | Jan 2024 | Feb 4, 2026 | none |
| Kung Winston | Chief Financial Officer | Jan 2024 | Feb 4, 2026 | none |
| Kastenmayer James Paul | General Counsel | Jan 2024 | Feb 4, 2026 | none |
Directorssales are open-market, Nov 2, 2025 to Nov 2, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hohneker John | director | May 2024 | Jun 22, 2026 | none |
| Nolet Chris | director | Jan 2024 | Jun 22, 2026 | none |
| Parsey Merdad | director | Apr 2025 | Jun 22, 2026 | none |
| Peterson Kristine | director | Apr 2024 | Jun 22, 2026 | none |
Owners of more than 10% of a classsales are open-market, Nov 2, 2025 to Nov 2, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hhlr Advisors, Ltd. | 10% owner | Jan 2024 | Feb 3, 2026 | 1 · $13.0M |
| Hillhouse Investment Management, Ltd. | 10% owner | Jan 2024 | Feb 3, 2026 | none |
Earlier names on the record7, newest filing first
Gordon Carl L · director · last filing Jan 2024Healy James · director · last filing Jan 2024Orbimed Advisors IV Ltd · director · last filing Jan 2024Orbimed Advisors LLC · director · last filing Jan 2024Orbimed Asia Gp IV, L.P. · director · last filing Jan 2024Orbimed Capital Gp Viii LLC · director · last filing Jan 2024Jallal Bahija · director · last filing Jan 2024
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.